Research shows twice-yearly PrEP injections prevent HIV in women
|
Lenacapavir, a twice-yearly injectable antiretroviral,
demonstrated 100% effectiveness for preventing HIV acquisition in a
large study of young ... |
New strategy targets rare B cells for effective HIV vaccine development
... epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human immunodeficiency virus ( HIV ). View article...